Your browser doesn't support javascript.
loading
Prognostic impact of complex karyotype on post-transplant outcomes of myelofibrosis.
Okada, Yosuke; Takenaka, Katsuto; Murata, Makoto; Shimazu, Yutaka; Tachibana, Takayoshi; Ozawa, Yukiyasu; Uchida, Naoyuki; Wakayama, Toshio; Doki, Noriko; Sugio, Yasuhiro; Tanaka, Masatsugu; Masuko, Masayoshi; Kobayashi, Hikaru; Ino, Kazuko; Ishikawa, Jun; Nakamae, Hirohisa; Matsuoka, Ken-Ichi; Kanda, Yoshinobu; Fukuda, Takahiro; Atsuta, Yoshiko; Nagamura-Inoue, Tokiko.
Affiliation
  • Okada Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Takenaka K; Department of Hematology, Ehime University Graduate School of Medicine, Clinical Immunology, and Infectious Diseases, Toon, Ehime, Japan.
  • Murata M; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Shimazu Y; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Tachibana T; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Aichi, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL, Tokyo, Japan.
  • Wakayama T; Department of Hematology and Oncology, Shimane Prefectural Central Hospital, Shimane, Japan.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Sugio Y; Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Fukuoka, Japan.
  • Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Masuko M; Department of Hematopoietic Cell Therapy, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Kobayashi H; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
  • Ino K; Department of Hematology and Oncology, Mie University Hospital, Mie, Japan.
  • Ishikawa J; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
  • Nakamae H; Department of Hematology, Osaka City University Hospital, Osaka, Japan.
  • Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Kanda Y; Division of Hematology, Jichi Medical University, Tochigi, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan.
  • Nagamura-Inoue T; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan.
Hematol Oncol ; 40(5): 1076-1085, 2022 Dec.
Article in En | MEDLINE | ID: mdl-35964301
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prognosis Type of study: Prognostic_studies Limits: Humans Language: En Journal: Hematol Oncol Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prognosis Type of study: Prognostic_studies Limits: Humans Language: En Journal: Hematol Oncol Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom